"Comparison of Intra-articular of 2% Ropivacaine vs. 7.5% Ropivacaine in Postoperative of Knee Arthroscopy" (ropivacaine)
Knee Arthroscopy, Acute Pain
About this trial
This is an interventional treatment trial for Knee Arthroscopy focused on measuring Knee Arthroscopy, Acute Pain, Ropivacaine
Eligibility Criteria
Inclusion Criteria: Mental health: healthy (not taking any medication) Articular cartilage lesion Grade I, II or III by Outerbridge Elective knee surgery Patients with any of the following diagnoses: Simple meniscal lesion Lesion of a single knee (unilateral) Exclusion Criteria: Neuromotor diseases (alterations in step, strength or sensitivity) History of knee surgery (orthopedic) Instability that includes knee ligament lesions Addictions Mental diseases in medical treatment Hepatic diseases Allergy to any of the medications used in the study Epidural or peridural anesthesia Chronic pain in treatment Postoperative drain of knee arthroscopy Pregnant or lactating
Sites / Locations
- American British Cowdray Medical Center
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Ropivacaine 7.5% Injectable Solution
Ropivacaine 2% Injectable Solution
The patients receive 10 ml of intraarticular solution in the knee (at the anatomical point at the level of the upper pole of the ball joint, under the iliotibial band), with different content of ropivacaine 7.5%; the vehicle for application presents the same physical appearance for all patients and is applied by previously standardized treating physicians.
The patients receive 10 ml of intraarticular solution in the knee (at the anatomical point at the level of the upper pole of the ball joint, under the iliotibial band), with different content of ropivacaine 2%; the vehicle for application presents the same physical appearance for all patients and is applied by previously standardized treating physicians.